Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 11:6:10-3.
doi: 10.1016/j.mmcr.2014.08.003. eCollection 2014 Oct.

Central nervous system cryptococcoma in a Ugandan patient with Human Immunodeficiency Virus

Affiliations

Central nervous system cryptococcoma in a Ugandan patient with Human Immunodeficiency Virus

Sruti S Velamakanni et al. Med Mycol Case Rep. .

Abstract

Mortality due to AIDS-related Cryptococcal meningitis (CM) is often >50% in low-middle income countries. Dissemination of CM can result in intracranial mass lesions known as cryptococcoma. Patients who develop cryptococcomas often have worse outcomes when compared to patients with cryptococcosis without cryptococcoma. We describe a cryptococcoma in the central nervous system (CNS) in a Ugandan patient with AIDS, and review the diagnosis and management with special focus on difficulties encountered in low or middle-income countries.

Keywords: Central nervous system; Cryptococcoma; Cryptococcus meningitis; Human Immunodeficiency Virus; Immunosuppressed Host.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Brain CT images showing evolution of cryptococcoma. 1a (left) The patient׳s CT image from October 2013, and 1b (right) the patient׳s CT image from December 2013.

References

    1. Jackson A, Hosseinipour MC. Management of cryptococcal meningitis in sub-Saharan Africa. Curr HIV/AIDS Rep. 2010;7(3):134–142. - PubMed
    1. Stevens DA, Denning DW, Shatsky S, Armstrong RW, Adler JD, Lewis BH. Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications. Mycopathologia. 1999;146(1):1–8. - PubMed
    1. Kambugu A, Meya DB, Rhein J, O׳Brien M, Janoff EN, Ronald AR. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis. 2008;46(11):1694–1701. - PMC - PubMed
    1. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis. 2000;31(2):499–508. - PubMed
    1. Musubire AK, Boulware DR, Meya DB, Rhein J. Diagnosis and management of cryptococcal relapse. J AIDS Clin Res. 2013;Sup 3(3):S3–003. - PMC - PubMed

LinkOut - more resources